Skip to content

Clinical trials

Phase 2 Vascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vascular Diseases Phase: Phase 2 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20051
20081
20093
20111
20121
20132
20142
20163
20171
20183
20193
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Active, not recruiting2
Unknown status2
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Complexa, Inc.2
Duke University2
Pulmovant, Inc.2
Abbott Medical Devices1
Akcea Therapeutics1
AnGes USA, Inc.1
AstraZeneca1
Brigham and Women's Hospital1
Bristol-Myers Squibb1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vascular Diseases27
Cardiovascular Diseases16
Arterial Occlusive Diseases6
Peripheral Arterial Disease6
Heart Diseases5
Arteriosclerosis4
Coronary Artery Disease4
Coronary Disease4
Hypertension, Pulmonary4
Lung Diseases4

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.